When should we be able to divert the cost of tuberculosis to other diseases?
作者信息
Mukhida Sahjid S, Das Nikunja K
机构信息
Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
出版信息
J Family Med Prim Care. 2023 May;12(5):1024-1025. doi: 10.4103/jfmpc.jfmpc_214_23. Epub 2023 May 31.
Abstract
摘要
相似文献
1
When should we be able to divert the cost of tuberculosis to other diseases?我们什么时候能够将用于结核病的费用转用于其他疾病？
J Family Med Prim Care. 2023 May;12(5):1024-1025. doi: 10.4103/jfmpc.jfmpc_214_23. Epub 2023 May 31.
2
Classifying home care clients' risk of unplanned hospitalization with the resident assessment instrument.用居民评估工具对家庭护理客户非计划性住院的风险进行分类。
Eur Geriatr Med. 2022 Oct;13(5):1129-1136. doi: 10.1007/s41999-022-00665-x. Epub 2022 Jun 27.
3
External validation of the detection of indicators and vulnerabilities for emergency room trips (DIVERT) scale: a retrospective cohort study.外部验证急诊就诊指标和脆弱性（DIVERT）量表：回顾性队列研究。
BMC Geriatr. 2020 Oct 20;20(1):413. doi: 10.1186/s12877-020-01816-0.
4
Evaluation of a novel flow diverter, the DiVeRt system, in an animal model.新型血流导向装置 DiVeRt 系统的动物模型评估。
J Neurointerv Surg. 2022 Apr;14(4):384-389. doi: 10.1136/neurintsurg-2021-017430. Epub 2021 May 13.
5
Social, economic and operational research on tuberculosis: recent studies and some priority questions.结核病的社会、经济与运营研究：近期研究及若干优先问题
Bull Int Union Tuberc Lung Dis. 1991 Dec;66(4):149-56.
6
Treatment of tuberculosis in complex emergencies in developing countries: a scoping review.发展中国家复杂紧急情况下的结核病治疗：范围综述。
Health Policy Plan. 2018 Mar 1;33(2):247-257. doi: 10.1093/heapol/czx157.
7
Costs of novel tuberculosis diagnostics--will countries be able to afford it?新型结核病诊断方法的成本——各国能否负担得起？
J Infect Dis. 2015 Apr 1;211 Suppl 2:S67-77. doi: 10.1093/infdis/jiu820.
8
Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens.针对痰涂片阳性呼吸道标本常规使用的基因探针扩增结核分枝杆菌直接检测法的成本效益分析。
J Clin Microbiol. 2003 Mar;41(3):948-53. doi: 10.1128/JCM.41.3.948-953.2003.
9
Cost-effectiveness and total costs of three alternative strategies for the prevention and management of severe skin reactions attributable to thiacetazone in the treatment of Human Immunodeficiency Virus positive patients with tuberculosis in Kenya.肯尼亚针对感染人类免疫缺陷病毒的结核病阳性患者，预防和处理因氨硫脲所致严重皮肤反应的三种替代策略的成本效益及总成本
Tuber Lung Dis. 1996 Feb;77(1):30-6. doi: 10.1016/s0962-8479(96)90072-6.
10
Cost-effectiveness analysis of silver diamine fluoride to divert dental general anaesthesia compared to standard care.银氨氟化物用于预防牙科全麻与标准护理的成本效益分析。
Aust Dent J. 2022 Dec;67(4):352-361. doi: 10.1111/adj.12936. Epub 2022 Sep 29.
引用本文的文献
1
Analyzing the distribution of virulence factors of and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi.利用全基因组测序分析乌鲁木齐不同谱系中 的毒力因子分布以及毒力基因突变对治疗结果的影响。
Virulence. 2025 Dec;16(1):2552875. doi: 10.1080/21505594.2025.2552875. Epub 2025 Sep 16.
2
Does malnutrition play an essential role in developing drug-resistant tuberculosis, and how can it be prevented?营养不良在耐药结核病的发展中是否起着至关重要的作用，以及如何预防？
J Family Med Prim Care. 2025 May;14(5):2087-2088. doi: 10.4103/jfmpc.jfmpc_1363_24. Epub 2025 May 31.
3
Reply to the syndemic of "COVID-19 and tuberculosis".对“新冠疫情与结核病并发流行”的回应。
J Family Med Prim Care. 2023 Sep;12(9):2185. doi: 10.4103/jfmpc.jfmpc_2175_22. Epub 2023 Sep 30.
本文引用的文献
1
The past, present, and future of health economics in India.印度卫生经济学的过去、现在与未来。
J Family Med Prim Care. 2022 Dec;11(12):7513-7516. doi: 10.4103/jfmpc.jfmpc_2266_21. Epub 2023 Jan 17.
2
Association of underweight status with the risk of tuberculosis: a nationwide population-based cohort study.体重不足与结核病风险的关联：一项全国性基于人群的队列研究。
Sci Rep. 2022 Sep 28;12(1):16207. doi: 10.1038/s41598-022-20550-8.
3
Are the Diagnosed Cases of Tuberculosis Just the Tip of Iceberg? Comments on "Syndemic of Tuberculosis and COVID-19 in Bangladesh".
Asia Pac J Public Health. 2022 Nov;34(8):875-876. doi: 10.1177/10105395221121049. Epub 2022 Aug 24.
4
Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study.印度西部国家结核病规划所治疗的结核病患者现金转移计划：一项混合方法研究
BMJ Open. 2019 Dec 29;9(12):e033158. doi: 10.1136/bmjopen-2019-033158.
5
Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents.免费的结核病诊断和治疗还不够：来自三大洲的患者费用证据。
Int J Tuberc Lung Dis. 2013 Mar;17(3):381-7. doi: 10.5588/ijtld.12.0368.
Zotero 插件